To be clear, we think that Canada should not be taking doses from COVAX. That being said, we think there's a bigger problem of production.
Even if we didn't take those million-plus doses, we still don't solve the problem for the world. There's no way, even once we're vaccinated in Canada, that we can go fast enough to vaccinate everyone else with the doses available now. That's why our focus today is on ramping up production and opening up intellectual property rights, so that developing countries that have the capacity to produce are doing it.
The problem with the current system is that someone like me, a young woman who's perfectly healthy, will be vaccinated before a health care worker in a developing country who is on the front lines of the disease.
That's why we need to shift things around. It's not a bidding war—who pays the most to get the vaccine—but that the vaccines are distributed according to need and vulnerability. That's not how things are working today, and there's an easy answer to this around intellectual property rights.